# FDA 483 - Central Pennsylvania Blood Bank - April 24, 2026

Source: https://www.keypedia.com/records/483/central-pennsylvania-blood-bank/0098e641-0457-415f-9a14-9d52725027a6

> FDA 483 for Central Pennsylvania Blood Bank on April 24, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Central Pennsylvania Blood Bank
- Inspection Date: 2026-04-24
- Product Type: biologics
- Office Name: Philadelphia District Office
- Summary: Central Pennsylvania Blood Bank in Hershey, PA, received a Form 483 following an inspection from April 23-24, 2026. The inspection revealed two significant observations related to donor screening and collection procedures. Issues included the failure to weigh apheresis donors and deficiencies in the medical history assessment process for transfusion-transmitted infection risks.

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/emily-a-walters/e80b3581-ffba-4244-9030-b6c9496da932)

Company: https://www.keypedia.com/companies/central-pennsylvania-blood-bank/979beab4-0c58-4a03-b817-816c3dca104a

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8